Pharmalot.. Pharmalittle.. Good Morning, Everyone
Hello, everyone, and welcome to another working week. The weekend respite flew by rather quickly, did it not? Well, that was to be expected. Now, the time has come to resume the usual routine of meetings and deadlines and what-not. So please join us as we fortify ourselves with a few cups of stimulation. A little edge can be a good thing, yes? Meanwhile, here are some tidbits to get you going. Have a smashing day and do stay in touch…
An agreement on the Trans Pacific Partnership trade pact is expected to be announced this morning and include a compromise on clinical trial data exclusivity on biologics; A single, 5,000 percent price hike on an anti-parasitic drug from Turing Pharmaceuticals garnered national media attention, but this was actually just one of hundreds of smaller price increases; A guerrilla advertising campaign in Australia is encouraging gay men to have unprotected sex in order to promote PrEP, a drug that combats HIV infection, but has not been approved for use there; and organizations involved in the anti-vaccine movement, such as SafeMinds, still hope to find some evidence that vaccines threaten children’s health, but a recent effort backfired.